Apollomics, Inc.
$13.53
0%
2026-04-21 05:20:01
www.apollomicsinc.com
NCM: APLM
Explore Apollomics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$15.34 M
Current Price
$13.53
52W High / Low
$42.12 / $3.66
Stock P/E
—
Book Value
$-3.99
Dividend Yield
—
ROCE
-737.55%
ROE
-3.8%
Face Value
—
EPS
$-26.64
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
13
Beta
1.83
Debt / Equity
0.2
Current Ratio
0.97
Quick Ratio
1.39
Forward P/E
-20.92
Price / Sales
4.21
Enterprise Value
$13.65 M
EV / EBITDA
-0.52
EV / Revenue
1.97
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | MannKind Corporation | $2.92 | 135.49 | $907.36 M | — | 7.49% | -9.03% | $6.51 / $2.23 | $-0.17 |
| 2. | Vyome Holdings, Inc. | $2.35 | — | $16.49 M | — | -73.02% | 1053.07% | $56.36 / $1.75 | $0.41 |
| 3. | Compass Therapeutics, Inc. | $5.42 | — | $1.08 B | — | -35.42% | -41.29% | $6.88 / $1.6 | $1.1 |
| 4. | Fulcrum Therapeutics, Inc. | $7.94 | — | $552.12 M | — | -24% | -25.3% | $15.74 / $2.92 | $5.24 |
| 5. | OSR Holdings, Inc. | $0.6 | — | $19.87 M | — | 79.82% | -20.03% | $1.79 / $0.38 | $3.46 |
| 6. | Upstream Bio, Inc. | $9.99 | — | $543.66 M | — | -47.12% | -35.44% | $33.68 / $7.25 | $6.26 |
| 7. | Omeros Corporation | $13.47 | — | $997.87 M | — | -49.6% | 2.21% | $17.65 / $2.95 | $-1.69 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -42.03 M | -54.37 M | -44.39 M | -50.27 M |
| Net Profit | -53.86 M | -172.6 M | -240.81 M | -94.8 M |
| EPS in Rs | -25.08 | -80.39 | -112.16 | -44.15 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 13.1 M | 55.39 M | 76.47 M | 123.44 M |
| Total Liabilities | 8.23 M | 14.15 M | 524.6 M | 336.3 M |
| Equity | 4.86 M | 41.23 M | -448.12 M | -212.86 M |
| Current Assets | 10.27 M | 39.92 M | 55.79 M | 99.37 M |
| Current Liabilities | 7.4 M | 13.56 M | 12.36 M | 13.56 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -28.74 M | -43.21 M | -42.82 M | -43.31 M |
| Investing CF | 5.98 M | 21.36 M | 29.05 M | -38.95 M |
| Financing CF | 0.47 M | 21.23 M | -0.29 M | -1.64 M |
| Free CF | -28.77 M | -43.22 M | -43.19 M | -50.86 M |
| Capex | -0.02 M | -0.01 M | -0.37 M | -7.55 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 68.8% | 28.33% | -154.03% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-11-25 | 1:0.01 |